In a report by Allison Aubrey on the NPR show “All Things Considered”, Dr. Abraham Palmer discuses new sources of caffeine in foods and beverages and how caffeine affects people differently. “There’s a lot of variation in the way people experience the effects of caffeine.” Click here to listen to the show and here to read an extended version.
Clarissa received a prestigious travel award; Abraham was accompanied by Stephanie Dulawa, his wife (they are both Associate Members) and Ariela, his 3 year old daughter. It was Ariela’s 3rd time at ACNP, meaning that she is among the few people who can honestly say that they’ve never missed ACNP.
Amy’s article: “Candidate gene studies of a promising intermediate phenotype: failure to replicate” has been accepted for publication in Neuropsychopharmacology. You can find the full article here.
Camron leaves the lab to start his new job in Boston. He will be assuming the position of Assistant Professor at Boston University School of Medicine in the Department of Pharmacology and Experimental Therapeutics.
Margaret and Abe’s review article: “Role of Glyoxalase 1 (Glo1) and methylglyoxal (MG) in behavior: recent advances and mechanistic insights” has been accepted for publication in Frontiers in Behavioral and Psychiatric Genetics. You can find the article here.
Clarissa’s presentation was on “Comparing genome-wide association results for fear conditioning in two advanced intercross mouse lines: Implications for gene identification in Post-traumatic Stress Disorder in humans” . Clarissa was accompanied to the World Congress by fellow lab members Amy Hart and Abraham Palmer.
An article by Virginia Hughes discussing post-traumatic stress disorder (PTSD) mentions Dr. Abraham Palmer’s work. You can find the full article here.
